Single-dose of BBV-152 and AZD1222 increases antibodies against spike glycoprotein among healthcare workers recovered from SARS-CoV-2 infection-Reference-Cited by-同舟云学术

Single-dose of BBV-152 and AZD1222 increases antibodies against spike glycoprotein among healthcare workers recovered from SARS-CoV-2 infection

Published:2021-11 Issue: Volume:44 Page:102170
ISSN:1477-8939
Container-title:Travel Medicine and Infectious Disease
language:en
Short-container-title:Travel Medicine and Infectious Disease

Author:

Parai Debaprasad^ORCID,Choudhary Hari Ram,Dash Girish Chandra,Sahoo Subrat Kumar,Pattnaik Matrujyoti,Rout Usha Kiran,Nanda Rashmi Ranjan,Kanungo Srikanta,Kshatri Jaya Singh,Pati Sanghamitra,Bhattacharya Debdutta^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference5 articles.

1. Editorial. India's COVID-19 emergency;Lancet,2021

2. COVID-19 dashboard,2021

3. MoHFW;Vaccination Dashboard,2021

4. A global database of COVID-19 vaccinations;Mathieu;Nat Hum Behav,2021

5. Binding and neutralization antibody titers after a single vaccine dose in health care workers previously infected with SARS-CoV-2;Saadat;J Am Med Assoc,2021

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational study;The Lancet Regional Health - Southeast Asia;2024-03

2. Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy;Frontiers in Immunology;2023-05-02

3. Interim results from comparison of immune responses elicited by an inactivated and a vectored SARS-CoV-2 vaccine in seronegative and seropositive participants in India;2023-01-05

4. Assessment of early and post COVID-19 vaccination antibody response in healthcare workers: a multicentre cross-sectional study on inactivated, mRNA and vector-based vaccines;Epidemiology and Infection;2023

5. An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines;Vaccines;2022-12-26